Inflammatory Biomarkers and Postoperative Delirium in Pediatric Circumcision
NCT ID: NCT07323485
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
140 participants
OBSERVATIONAL
2026-01-10
2026-07-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association of Inflammatory Markers With Preoperative Anxiety and Agitation
NCT06648122
Evaluation of Preoperative Risk Factors in Children
NCT05852899
Preoperative Information With Storybook for Pediatric Anesthesia
NCT06382025
İntraoperative Awareness Under General Anesthesia
NCT04697732
The Effect of Premedication Type(Pharmalogical and Non Pharmalogical) on Delirium
NCT03426020
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measurement of Preoperative Inflammatory Biomarkers
Blood samples will be collected preoperatively to assess inflammatory biomarkers, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), monocyte-to-lymphocyte ratio (MLR), and the systemic inflammation response index (SIRI). These parameters will be analyzed in relation to the incidence of emergence delirium within the first 2 hours following pediatric circumcision.
No experimental drug or medical device will be used as part of the study; all procedures will be performed within the scope of standard perioperative care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients scheduled to undergo elective circumcision under general anesthesia.
* Patients classified as ASA physical status I-II.
* Patients whose parents or legal guardians provide written informed consent, and whose age-appropriate verbal assent is obtained from the child.
* Patients in whom anesthesia and surgical procedures are performed according to standard institutional protocols throughout the study period.
Exclusion Criteria
* Patients classified as ASA physical status III-IV.
* Patients with incomplete preoperative laboratory data or with hematological or hormonal disorders that may affect inflammatory parameters.
* Patients who develop excessive sedation after premedication or whose preoperative assessment cannot be completed.
* Patients with protocol deviations during surgery or anesthesia (e.g., additional medications, prolonged surgical duration, or changes in procedure due to complications).
* Patients whose parents or legal guardians do not provide consent or who decline participation.
2 Years
12 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Etlik City Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmet Murat Gul
Specialist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Etlik City Hospital
Altındağ, Ankara, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AEŞH-EK-2025-299
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.